Hiroyuki Namba

Clinical Implication of Hot Spot<i>BRAF</i>Mutation, V599E, in Papillary Thyroid Cancers

Hiroyuki Namba, Masahiro Nakashima, Tomayoshi Hayashi et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 539 citations

Medicine, Genetics, Oncology +17

Point Mutations of Ras Oncogenes are an Early Event in Thyroid Tumorigenesis

Hiroyuki Namba, Stanley A. Rubin, James A. Fagin · Molecular Endocrinology · 1990 · 362 citations

Medicine, Genetics, Molecular Genetics +17

Oncogenic role of miR‐17‐92 cluster in anaplastic thyroid cancer cells

Shu Takakura, Norisato Mitsutake, Masahiro Nakashima et al. · Cancer Science · 2008 · 245 citations · Full text

Medicine, Cancer Biology, Oncology +16

Characterization of Side Population in Thyroid Cancer Cell Lines: Cancer Stem-Like Cells Are Enriched Partly But Not Exclusively

Norisato Mitsutake, Atsuhiko Iwao, Kazuhiro Nagai et al. · Endocrinology · 2007 · 229 citations

Medicine, Cell Biology, Oncology +15

Low Frequency of BRAFT1796A Mutations in Childhood Thyroid Carcinomas

Atsushi Kumagai, Hiroyuki Namba, Vladimir Saenko et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 144 citations

Medicine, Genetics, Oncology +17